Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Koenig Scott, Director. Officer active across 3 companies, notably Glycomimetics INC. In total, 13 disclosures have been recorded. Activity tracked since 18 May 2021. The latest transaction was filed on 15 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations
Koenig Scott is Director at Macrogenics INC, Glycomimetics INC, and Applied Genetic Technologies CORP. He has 13 filings in total, and among the sampled recent filings, the period runs from 2021-05-27 to 2026-02-17. Buy and sell amounts are 0, and the main recent filings concern Macrogenics INC and Glycomimetics INC, with amounts of 77048.06060949207, 24576.77447818735, and 11709.17996105598.